Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11140841 | 0.82 | CRBN (0.34) | CRBNDDB1 | |
| SCHEMBL2676051 | 0.78 | CRBN (0.33) | CRBNDDB1 | |
| SCHEMBL14256466 | 0.78 | CRBN (0.32) | CRBNDDB1 | |
| SCHEMBL18356170 | 0.75 | CRBN (0.33) | CRBNDDB1 | |
| SCHEMBL10151268 | 0.74 | SSTR5 (0.33) | CRBN | |
| SCHEMBL2209079 | 0.74 | SMN1; SMN2 (0.34) | CRBNDDB1 | |
| SCHEMBL11271579 | 0.72 | CRBN (0.32) | CRBNDDB1 | |
| SCHEMBL3087790 | 0.71 | PAOX (0.38) | CRBNDDB1 | |
| SCHEMBL18697242 | 0.70 | CRBN (0.41) | CRBNDDB1 | |
| SCHEMBL10151274 | 0.70 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7776182-B2 | Chlorohydrin and cationic compounds having high affinity for pulp or paper | CIBA SPECIALTY CHEMICALS CORPORATION (US) | 2010-08-17 | — | — | US | disclosed |
| US-20080060775-A1 | Chlorohydrin and cationic compounds having high affinity for pulp or paper | CUNKLE GLEN T | 2008-03-13 | — | — | US | disclosed |
| US-7312332-B2 | Such as 1-butyl-3-hydroxy-1-[2-hydroxy-3-(1-oxyl-2,2,6,6-tetramethyl-piperidin-4-yloxy)-propyl]-azetidinium chloride; yellowing and discoloration prevention; ultraviolet, fluorescent and solar light stability; expanding use of high yield pulps to higher grade products | CIBA SPECIALTY CHEMICALS CORPORATION (US) | 2007-12-25 | — | — | US | disclosed |
| US-7312332-B2 | Such as 1-butyl-3-hydroxy-1-[2-hydroxy-3-(1-oxyl-2,2,6,6-tetramethyl-piperidin-4-yloxy)-propyl]-azetidinium chloride; yellowing and discoloration prevention; ultraviolet, fluorescent and solar light stability; expanding use of high yield pulps to higher grade products | CIBA SPECIALTY CHEMICALS CORPORATION (US) | 2007-12-25 | — | — | US | disclosed |
| US-6989449-B1 | Chlorohydrin and cationic compounds having high affinity for pulp or paper | CIBA SPECIALTY CHEMICALS CORPORATION (US) | 2006-01-24 | — | — | US | disclosed |
| US-20050092452-A1 | Chlorohydrin and cationic compounds having high affinity for pulp or paper | CUNKLE GLEN T (US) | 2005-05-05 | — | — | US | disclosed |
| EP-1212486-B1 | CHLOROHYDRIN AND CATIONIC COMPOUNDS HAVING HIGH AFFINITY FOR PULP OR PAPER | CIBA SC HOLDING AG (CH) | 2005-04-06 | — | — | EP | disclosed |
| EP-1212486-A1 | CHLOROHYDRIN AND CATIONIC COMPOUNDS HAVING HIGH AFFINITY FOR PULP OR PAPER | Ciba SC Holding AG (CH) | 2002-06-12 | — | — | EP | disclosed |
| WO-2001020078-A1 | CHLOROHYDRIN AND CATIONIC COMPOUNDS HAVING HIGH AFFINITY FOR PULP OR PAPER | CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) | 2001-03-22 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080060775-A1 | Chlorohydrin and cationic compounds having high affinity for pulp or paper | NISCH, HNMT, LCT | CRBN 1192/4885DDB1 292/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.